Range
1.87 - 2.04
Vol / Avg.
1.8M/2.2M
Div / Yield
-
52 Wk
1.44 - 8.18
Mkt Cap
24.1M
Payout Ratio
-
Open
2
P/E
-
EPS
-0.35
Shares
12.6M
Outstanding
12.6M
Total Float
9.2M
Sector: Health Care.Industry: Pharmaceuticals
Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company's lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through a proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.420-0.390 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EYEGEyegate Pharmaceuticals-9.05%24.1M

Eyegate Pharmaceuticals Questions & Anwsers

Q

How do I buy Eyegate Pharmaceuticals (EYEG) stock?

A

You can purchase shares of Eyegate Pharmaceuticals (NASDAQ: EYEG) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Eyegate Pharmaceuticals's (EYEG) competitors?

Q

What is the target price for Eyegate Pharmaceuticals (EYEG) stock?

A

The latest price target for Eyegate Pharmaceuticals (NASDAQ: EYEG) was reported by HC Wainwright & Co. on August 16, 2021. The analyst firm set a price target for 11.00 expecting EYEG to rise to within 12 months (a possible 475.92% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Eyegate Pharmaceuticals (EYEG)?

A

The stock price for Eyegate Pharmaceuticals (NASDAQ: EYEG) is $1.91 last updated Fri Sep 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Eyegate Pharmaceuticals (EYEG) pay a dividend?

A

There are no upcoming dividends for Eyegate Pharmaceuticals.

Q

When is Eyegate Pharmaceuticals (NASDAQ:EYEG) reporting earnings?

A
Eyegate Pharmaceuticals’s Q3 earnings are confirmed for after-market on November 8, 2021.
Q

Is Eyegate Pharmaceuticals (EYEG) going to split?

A

There is no upcoming split for Eyegate Pharmaceuticals.

Q

What sector and industry does Eyegate Pharmaceuticals (EYEG) operate in?

A

Eyegate Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.